A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity
Image
Description
article by Sven J. van der Lee et al published 27 May 2019 in Acta Neuropathologica